Wide Ranks

IZTC

Invizyne Technologies Inc.

13.47

Top Statistics
Market Cap 128 M Forward PE 0.0000 Revenue Growth 0.00 %
Current Ratio 0.24 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -19.00 Enterprise / Revenue -126922.01 Price To Sales Trailing12 Months -183361.34
Profitability
Profit Margins 0.00 % Operating Margins 704833.70 %
Balance Sheet
Total Cash 233935 Total Cash Per Share 0.0370 Total Debt 4 M
Total Debt To Equity Current Ratio 0.24 Book Value Per Share -0.5760
All Measures
Short Ratio 21.00 % Message Board Id finmb_1687004448 City Monrovia
Uuid 11497109-e9a9-3699-a161-9349790fd731 Previous Close 13.84 First Trade Date Epoch Utc 1 B
Book Value -0.5760 Total Debt 4 M Volume 6962
Fifty Two Week Low 8.50 Total Cash Per Share 0.0370 Total Revenue -700
Max Age 86400 Sand P52 Week Change 0.3133 Operating Margins 704833.70 %
Net Income To Common -5123925 Ask 15.59 Short Percent Of Float 0.0045
Implied Shares Outstanding 9 M Last Fiscal Year End 1 B Trailing Peg Ratio None
Average Daily Volume10 Day 44180 Average Volume10days 44180 Total Cash 233935
Next Fiscal Year End 1 B Held Percent Insiders 0.7634 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 13.84
Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000 Fifty Day Average 12.65
Open 14.10 Free Cashflow -2354276 State CA
Dividend Yield 0.00 % Return On Assets -0.8829 Time Zone Short Name EST
Trailing Eps -0.6300 Day Low 13.45 Address1 750 Royal Oaks Drive
Shares Outstanding 9 M Price Hint 2 Target High Price 0.0000
Website https://www.invizyne.com 52 Week Change 0.5572 Average Volume 45372
Recommendation Key none Forward Eps 0.0000 Compensation As Of Epoch Date 1 B
Quick Ratio 13.60 % Is_sp_500 False Regular Market Day High 14.97
Profit Margins 0.00 % Fifty Two Week High 19.37 Day High 14.97
Shares Short 10174 Regular Market Open 14.10 Industry Key biotechnology
Bid 13.75 Earnings Growth 0.00 % Enterprise To Revenue -126922.01
Revenue Growth 0.00 % Shares Percent Shares Out 0.0012 Operating Cashflow -3581403
Currency USD Time Zone Full Name America/New_York Market Cap 128 M
Is_nasdaq_100 False Zip 91016 Quote Type EQUITY
Industry Biotechnology Long Name Invizyne Technologies, Inc. Regular Market Day Low 13.45
Current Price 13.47 Address2 Suite 106 Enterprise To Ebitda -19.00
Financial Currency USD Current Ratio 0.24 Industry Disp Biotechnology
Country United States Two Hundred Day Average 12.65 Enterprise Value 88 M
Price To Sales Trailing12 Months -183361.34 Forward PE 0.0000 Regular Market Volume 6962
Ebitda -4675055 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States.

The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds.

Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion.

The company was founded in 2014 and is headquartered in Monrovia, California.